- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07423416
Validation of the Modified Cognitive Assessment Scale (MoCA Blind) for the Diagnosis of Postoperative Neurocognitive Disorders in Patients With Corneal Pathology in Russia.
Long-term observation has shown that patients with visual impairment often develop cognitive impairments. Due to the fact that patients who are planning to undergo corneal transplantation may have initial cognitive deficits, assessing cognitive function is an important aspect of work for both the anesthesiologist and the operating surgeon. Given the high significance of assessing cognitive function after anesthesia in ophthalmic surgery patients, it is relevant to adapt and validate the Russian version of the MoCA Blind test for subsequent use in clinical practice.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Alexandr Alexandr Romanov
- Phone Number: +79182942721
- Email: Saha_ro@mail.ru
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Russian-speaking patients with corneal pathology who are planning a corneal transplant in the future
Description
Inclusion Criteria:
- patients with corneal pathology, including burns, ulcers, dystrophies, and keratoectasia, as well as those with a history of corneal injuries
- physical status of I-III on the ASA scale.
Exclusion Criteria:
- children
- patients with sensorineural hearing loss
- patients with chronic cerebrovascular disorders
- patients with initially high levels of anxiety and depressive symptoms
- patients with severe cognitive impairments.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
postoperative neurocognitive disorders
Time Frame: From the moment of inclusion in the study until the end of treatment 90 days later
|
Postoperative neurocognitive disorders were identified by comparing the results of neuropsychological tests performed before surgery and on the 90th day after surgery. An individual Z-score was used for each domain of the test. |
From the moment of inclusion in the study until the end of treatment 90 days later
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SNF1
- № 143 01.01.2026 (Other Identifier: the Krasnodar Branch The S.Fyodorov Eye Microsurgery Federal State Institution)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
No final decision has been made.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.